Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation
Por:
Langebrake, C, Admiraal, R, van Maarseveen, E, Bonnin, A, Bauters, T, Black, A, Domingos, V, Pires, Martinez, MEM, EBMT Working Grp
Publicada:
1 ene 2020
Resumen:
Filiaciones:
Langebrake, C:
Univ Med Ctr Hamburg Eppendorf, Hosp Pharm, Hamburg, Germany
Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
Admiraal, R:
Univ Med Ctr, Dept Pediat, Utrecht, Netherlands
Princess Maxima Ctr Pediat Oncol, Pediat Blood & Marrow Transplant Program, Utrecht, Netherlands
van Maarseveen, E:
Princess Maxima Ctr Pediat Oncol, Pediat Blood & Marrow Transplant Program, Utrecht, Netherlands
Univ Med Ctr, Clin Pharm, Utrecht, Netherlands
Bonnin, A:
St Antoine Hosp, Hematol & Cellular Therapy Dept, Paris, France
Bauters, T:
Ghent Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplantat, Ghent, Belgium
Black, A:
Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
Domingos, V:
Portuguese Oncol Inst Lisbon, Lisbon, Portugal
Pires:
Portuguese Oncol Inst Lisbon, Lisbon, Portugal
Martinez, MEM:
Hosp Santa Creu & Sant Pau, Serv Farm, Barcelona, Spain
|